Client Result
Orrick Advises Ananda Pharma on U.S. OTCQB Listing
April.16.2025
Orrick advised Ananda Pharma plc on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the U.S.
April.16.2025
Orrick advised Ananda Pharma plc on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the U.S.
March.20.2025
Orrick advised Cobra Resources plc (LSE: PALM) on its London Stock Exchange Main Market placing and associated secondary prospectus.
February.27.2025
December.18.2024
September.25.2023
August.22.2023
A cross-border Orrick team advised RegTech Open Project plc (LSE: RTOP) on its £60 million direct listing on the London Stock Exchange.
July.20.2023
June.30.2023
May.10.2023
May.03.2023
February.23.2023
January.23.2023
The Lawyer has recognized Orrick partner Ed Dyson in its “Hot 100 2023” list of professionals celebrated for legal excellence and relevance.